External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA

NCT05495204 · clinicaltrials.gov ↗

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Ibalizumab

Sponsor

Epividian

Collaborators

[object Object]
[object Object]